Israel: Cholesterol-lowering drugs may help treat new coronapneumonia.

Over the past three months, Professor Nahamias and DrBenjamin Tenoerwall of Mount Sinai Medical Center in New York have studied the way the new coronavirus alters a patient's lungs for its own replicationtheir important finding is that the new coronavirus blocks the regular metabolism of carbohydrates, resulting in a large amount of fat accumulating inside the lungs, allowing the new coronavirus to replicatethese new understandings and understandings of the new coronavirus may help explain why people with high blood sugar and high cholesterol are particularly at risk of developing new coronal pneumonia after contracting the virus, after obtaining the information, Nahamias and Tenoerwal began screening drugs approved by the U.SFood and Drug Administration that interfere with virus replicationin laboratory studies, they found that the cholesterol-lowering drug non-nobert (anti-lipid drug) showed promising resultsresearchers believe that non-Norbert destroys the virus's domination of lung cells by allowing lung cells to consume more fatthey report in a professional journal this week that after five days of treatment, the virus has almost completely disappearedNahamias said the new findings were timely as the second wave of infections spread across several countries around the worldif the new findings are ultimately confirmed by clinical studies, the use of a non-Nobert treatment could downgrade the impact of the new coronavirus on patients from severe to common cold-like.